Mariana Junqueira Pedras
Overview
Explore the profile of Mariana Junqueira Pedras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freire M, Alves L, de Souza C, Saliba J, Faria V, Pedras M, et al.
PLoS One
. 2022 Jun;
17(6):e0269997.
PMID: 35709075
A rapid and accurate diagnosis is a crucial strategy for containing the coronavirus disease (COVID-19) pandemic. Considering the obstacles to upscaling the use of RT-qPCR, rapid tests based on antigen...
2.
Cota G, Freire M, de Souza C, Pedras M, Saliba J, Faria V, et al.
Int J Infect Dis
. 2020 Oct;
101:382-390.
PMID: 33039612
Objectives: To access the performance of 12 serological tests for COVID-19 diagnosis. Methods: We conducted a blind evaluation of six lateral-flow immunoassays (LFIAs) and six enzyme-linked immunosorbent assays (ELISAs) commercially...
3.
Galvao E, Assis T, Pedras M, Cota G, Simoes T, Rabello A
Cad Saude Publica
. 2020 Jul;
36(7):e00136419.
PMID: 32696829
Cutaneous leishmaniasis (CL) is a disease associated with low-income populations. Thus, in assessing the burden of this disease, it is important to include its economic impact on individuals. We aimed...
4.
Galvao E, Pedras M, Cota G, Rabello A, Simoes T
PLoS One
. 2019 Jan;
14(1):e0211374.
PMID: 30682151
Background: Until now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patients' quality of life, and none have used a specific instrument to measure this effect. The...
5.
Galvao E, Pedras M, Cota G, Simoes T, Rabello A
PLoS One
. 2018 Aug;
13(8):e0203378.
PMID: 30161222
Background: The impact of cutaneous leishmaniasis (CL) on the quality of life of patients has been neglected in research studies worldwide. The few reported studies have used non-specific questionnaires for...
6.
Pedras M, de Pina Carvalho J, Silva R, Ramalho D, Senna M, Moreira H, et al.
Rev Soc Bras Med Trop
. 2018 Jul;
51(3):318-323.
PMID: 29972562
Introduction: Pentavalent antimonials (Sbv) are the most commonly used drugs for the treatment of mucosal leishmaniasis (ML), despite their high toxicity and only moderate efficacy. The aim of this study...
7.
Ramalho D, Silva R, Senna M, Moreira H, Pedras M, Avelar D, et al.
Mem Inst Oswaldo Cruz
. 2018 Jun;
113(9):e180200.
PMID: 29947651
Background: Cutaneous leishmaniasis (CL) is a world-wide health problem which currently lacks effective, affordable and easy to use therapy. Recently, the meglumine antimoniate (MA) intralesional infiltration was included among the...
8.
Oliveira E, Pedras M, de Assis I, Rabello A
Trans R Soc Trop Med Hyg
. 2009 May;
103(12):1279-81.
PMID: 19457530
We previously standardized the direct agglutination test (DAT) to detect anti-Leishmania chagasi promastigote antibodies (DAT-LPC) with good sensitivity and specificity for diagnosing visceral leishmaniasis (VL). In this paper, we present...
9.
Pedras M, de Gouvea Viana L, de Oliveira E, Rabello A
Trans R Soc Trop Med Hyg
. 2007 Dec;
102(2):172-8.
PMID: 18160087
Five serological tests for the diagnosis of visceral leishmaniasis (VL) were compared: a direct agglutination test (DAT) based on freeze-dried antigen (DAT-fd); a locally produced DAT (DAT-LPC); an IgG ELISA...
10.
Disch J, Pedras M, Orsini M, Pirmez C, de Oliveira M, Castro M, et al.
Diagn Microbiol Infect Dis
. 2005 Mar;
51(3):185-90.
PMID: 15766604
The utility of 2 polymerase chain reaction (PCR)-based assays amplifying genus or Viannia subgenus Leishmania minicircle kDNA for the diagnostics of ML was assessed. The Viannia subgenus product was yielded...